EXHIBIT 10.6 [PAIN THERAPEUTICS, INC. LETTERHEAD] CONSULTING AGREEMENT, SETTLEMENT AGREEMENT AND MUTUAL RELEASE This Consulting Settlement Agreement and Mutual Release ("Agreement") is made by and between Pain Therapeutics, Inc. (the "Company") and...Consulting Agreement • March 22nd, 2002 • Pain Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 22nd, 2002 Company Industry Jurisdiction
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 20th, 2018 • Pain Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 20th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 15, 2018, between Pain Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCKUnderwriting Agreement • June 20th, 2000 • Pain Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 20th, 2000 Company Industry Jurisdiction
COMMON STOCK PURCHASE WARRANT Pain Therapeutics, Inc.Pain Therapeutics Inc • August 20th, 2018 • Pharmaceutical preparations
Company FiledAugust 20th, 2018 IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________ (the “Termination Date”) but not thereafter, to subscribe for and purchase from Pain Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 22nd, 2022 • Cassava Sciences Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 22nd, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of November 18, 2022, between Cassava Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Capital On DemandTM Sales AgreementCassava Sciences Inc • May 1st, 2023 • Pharmaceutical preparations • New York
Company FiledMay 1st, 2023 Industry JurisdictionCassava Sciences, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), as follows:
Sales AgreementSales Agreement • March 27th, 2020 • Cassava Sciences Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 27th, 2020 Company Industry JurisdictionCassava Sciences, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC (the “Agent”), as follows:
1 LEASE -----Pain Therapeutics Inc • March 14th, 2000 • California
Company FiledMarch 14th, 2000 Jurisdiction
WITNESSETHResearch Agreement • March 14th, 2000 • Pain Therapeutics Inc • Indiana
Contract Type FiledMarch 14th, 2000 Company Jurisdiction
RECITALSEmployment Agreement • March 14th, 2000 • Pain Therapeutics Inc • California
Contract Type FiledMarch 14th, 2000 Company Jurisdiction
INDEMNIFICATION AGREEMENTIndemnification Agreement • March 1st, 2022 • Cassava Sciences Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 1st, 2022 Company Industry JurisdictionThis Indemnification Agreement (“Agreement”) is made as of this _____ day of _____________, 202_, by and between CASSAVA SCIENCES, INC., a Delaware corporation (the “Company”), and _________________________ (“Indemnitee”).
PAIN THERAPEUTICS, INC. and COMPUTERSHARE SHAREOWNER SERVICES LLC AMENDED AND RESTATED PREFERRED STOCK RIGHTS AGREEMENT Dated as of June 20, 2013Preferred Stock Rights Agreement • June 20th, 2013 • Pain Therapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJune 20th, 2013 Company Industry JurisdictionThis Amended and Restated Preferred Stock Rights Agreement (the “Agreement”) is dated as of June 20, 2013, between Pain Therapeutics, Inc., a Delaware corporation, (the “Company”), and Computershare Shareowner Services LLC (f/k/a Mellon Investor Services LLC) (the “Rights Agent”).
RECITALSRights Agreement • March 14th, 2000 • Pain Therapeutics Inc • California
Contract Type FiledMarch 14th, 2000 Company Jurisdiction
Form of Agreements for the 2008 Equity Incentive Plan PAIN THERAPEUTICS, INC. RESTRICTED STOCK UNIT AWARD AGREEMENTRestricted Stock Unit Award Agreement • July 30th, 2008 • Pain Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledJuly 30th, 2008 Company Industry JurisdictionUnless otherwise defined herein, the terms defined in the Pain Therapeutics, Inc. 2008 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Unit Award Agreement (the “Award Agreement”).
PAIN THERAPEUTICS, INC. RESTRICTED STOCK AWARD AGREEMENTRestricted Stock Award Agreement • July 30th, 2008 • Pain Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledJuly 30th, 2008 Company Industry JurisdictionUnless otherwise defined herein, the terms defined in the Pain Therapeutics, Inc. 2008 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Award Agreement (the “Award Agreement”).
LOGO]Pain Therapeutics Inc • August 11th, 2000 • Pharmaceutical preparations
Company FiledAugust 11th, 2000 Industry
PAIN THERAPEUTICS, INC. STOCK OPTION AWARD AGREEMENTStock Option Award Agreement • July 30th, 2008 • Pain Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledJuly 30th, 2008 Company Industry JurisdictionUnless otherwise defined herein, the terms defined in the Pain Therapeutics, Inc. 2008 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Stock Option Award Agreement (the “Award Agreement”).
STRICTLY CONFIDENTIAL Pain Therapeutics, Inc.Letter Agreement • August 20th, 2018 • Pain Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 20th, 2018 Company Industry Jurisdiction
EXHIBIT 99.1 [THE BOND MARKET ASSOCIATION LOGO] MASTER SECURITIES LOAN AGREEMENT Dated as of --------------------------------------------------------- ----------------------- Between: CITIGROUP GLOBAL MARKETS INC. ----------------...Master Securities Loan Agreement • June 23rd, 2003 • Pain Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 23rd, 2003 Company Industry Jurisdiction
1 EXHIBIT 10.1 PAIN THERAPEUTICS, INC. INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT ("AGREEMENT") is made as of this ______ day of _____________, ______, by and between PAIN THERAPEUTICS, INC., a Delaware corporation (the "COMPANY"), and...Indemnification Agreement • March 14th, 2000 • Pain Therapeutics Inc • Delaware
Contract Type FiledMarch 14th, 2000 Company Jurisdiction
LICENSE AGREEMENTLicense Agreement • May 9th, 2012 • Pain Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 9th, 2012 Company Industry JurisdictionThis License Agreement (the “Agreement”) is made effective this day of , 2005 by and between PAIN THERAPEUTICS, INC., a Delaware corporation with a principal place of business at 416 Browning Way, South San Francisco, CA 94080 (“PTI”) and KING PHARMACEUTICALS, INC., a Tennessee corporation with a principal place of business at 501 Fifth Street, Bristol, TN 37620 (“King”). Each of King and PTI is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
WARRANT AGREEMENT Dated as of January 3, 2024 between CASSAVA SCIENCES, INC. and COMPUTERSHARE INC. and COMPUTERSHARE TRUST COMPANY, N.A. as Warrant Agent Warrants for Shares of Common Stock of Cassava Sciences, Inc.Warrant Agreement • January 3rd, 2024 • Cassava Sciences Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 3rd, 2024 Company Industry JurisdictionWARRANT AGREEMENT, dated as of January 3, 2024 (this “Agreement”), between Cassava Sciences, Inc., a corporation incorporated under the laws of the state of Delaware (the “Company”), Computershare Inc., a Delaware corporation (“Computershare”), and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company, collectively as Warrant Agent (the “Warrant Agent”) (each a “Party” and collectively, the “Parties”).
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • April 24th, 2013 • Pain Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledApril 24th, 2013 Company Industry Jurisdiction
Exhibit 99.1 Master Securities Loan Agreement Public Securities Association 40 Broad Street, New York, NY 10004-2373 Telephone (212) 809-7000 MASTER SECURITIES LOAN AGREEMENT Dated as of __________ __, 2003 Between: Remi Barbier and...Securities Loan Agreement • July 18th, 2003 • Pain Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 18th, 2003 Company Industry Jurisdiction
PAIN THERAPEUTICS, INC. PERFORMANCE SHARE AWARD AGREEMENTPerformance Share Award Agreement • July 30th, 2008 • Pain Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledJuly 30th, 2008 Company Industry JurisdictionUnless otherwise defined herein, the terms defined in the 2008 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Performance Share Award Agreement (the “Award Agreement”).
COLLABORATION AGREEMENTCollaboration Agreement • February 9th, 2012 • Pain Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 9th, 2012 Company Industry JurisdictionThis COLLABORATION AGREEMENT is entered into as of November 9, 2005 (the “Effective Date”), by and between PAIN THERAPEUTICS, INC., a Delaware corporation having an address of 416 Browning Way, South San Francisco, California 94080 (“PTI”), and KING PHARMACEUTICALS, INC., a Tennessee corporation having an address of 501 Fifth Avenue, Bristol, Tennessee 37620 (“King”). Each of King and PTI is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
AMENDMENT TO PREFERRED STOCK RIGHTS AGREEMENT BETWEEN PAIN THERAPEUTICS, INC. AND MELLON INVESTOR SERVICES LLCPreferred Stock Rights Agreement • September 27th, 2006 • Pain Therapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 27th, 2006 Company Industry JurisdictionTHIS AMENDMENT TO PREFERRED STOCK RIGHTS AGREEMENT (the “Amendment”) is made this 27th day of September 2006, by and between PAIN THERAPEUTICS, INC., a Delaware corporation (the “Company”), and MELLON INVESTOR SERVICES LLC (the “Rights Agent”) to amend the Preferred Stock Rights Agreement, dated April 28, 2005, by and between the Company and the Rights Agent (the “Rights Agreement”).
Letter Agreement dated October 21, 2013 with Amendments to the License and Collaboration Agreements between the Registrant and King Pharmaceuticals, Inc.Letter Agreement • February 5th, 2014 • Pain Therapeutics Inc • Pharmaceutical preparations
Contract Type FiledFebruary 5th, 2014 Company IndustryThe signatories below are parties to agreements by which Pfizer is the sublicensee of rights granted by PTI as set forth in the License Agreement ("LA") dated as of November 9, 2005, as amended , by and between PTI and Pfizer, and the Collaboration Agreement ("CA"), dated as of November 9, 2005, as amended, by and between PTI and Pfizer. PTI is the licensee of rights granted by Durect Corporation ("Durect") as set forth in the Development and License Agreement dated as of December 19, 2002, as amended (the "DLA"), by and between PTI and Durect related to the development and commercialization of opioid agonist products incorporating the SABER Technology, the first of these being the oxycodone product Remoxy as defined in the CA.
SEPTEMBER 21, 2011 FIRST AMENDMENT TO LEASE AGREEMENTLease Agreement • February 9th, 2012 • Pain Therapeutics Inc • Pharmaceutical preparations
Contract Type FiledFebruary 9th, 2012 Company IndustryRe: Lease Agreement dated December 28, 2010, by and between STONECLIFF OFFICE, L.P., as Lessor, and PAIN THERAPEUTICS, INC., as Lessee, (herein after referred to as the “Lease Agreement”), demising 5,679 rentable square feet of space locally known as Suite 260 in the StoneCliff building, located at 7801 Capital of Texas Highway, Austin, Travis County, Texas, 78731.
Pain Therapeutics, Inc. 8,000,000 Shares1 Common Stock ($0.001 par value) Underwriting AgreementPain Therapeutics Inc • October 7th, 2004 • Pharmaceutical preparations • New York
Company FiledOctober 7th, 2004 Industry Jurisdiction
CONSULTING AGREEMENTConsulting Agreement • April 29th, 2004 • Pain Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledApril 29th, 2004 Company Industry JurisdictionThis Consulting Agreement (“Agreement”) is made and entered into as of March 24, 2004 by and between Pain Therapeutics, Inc. (the “Company”), and Richard Stevens (“Consultant”). The Company desires to retain Consultant as an independent contractor to perform consulting services for the Company and Consultant is able and willing to perform such services, on terms set forth more fully below. In consideration of the mutual promises contained herein, the parties agree as follows:
Pain Therapeutics, Inc. Shares[1] Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • September 4th, 2003 • Pain Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 4th, 2003 Company Industry JurisdictionPain Therapeutics, Inc., a corporation organized under the laws of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, [ ] shares of Common Stock, $0.001 par value (“Common Stock”), of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to [ ] additional shares of Common Stock to cover over-allotments (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requires. Any
December 21, 2005Pain Therapeutics Inc • February 24th, 2006 • Pharmaceutical preparations
Company FiledFebruary 24th, 2006 Industry
PAIN THERAPEUTICS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • February 13th, 2009 • Pain Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledFebruary 13th, 2009 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made by and between Pain Therapeutics, Inc., a Delaware corporation (the “Company”) and Remi Barbier (“Executive”) as of July 1, 1998.
AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENTEmployment Agreement • August 1st, 2013 • Pain Therapeutics Inc • Pharmaceutical preparations
Contract Type FiledAugust 1st, 2013 Company IndustryThis Amendment No. 2 to Employment Agreement (the “Amendment”) is made by and between Remi Barbier (the “Executive”) and Pain Therapeutics, Inc., a Delaware corporation (the “Company” and together with the Executive hereinafter collectively referred to as the “Parties”), on June 20, 2013.